Showing results (441-450 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|December 7, 2023
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
The Lancet. Diabetes & Endocrinology|December 7, 2023
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trialKausik K Ray, Stephen J Nicholls, Na Li, et al.
The Lancet. Diabetes & Endocrinology|March 4, 2024
Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centresAndrew A Dwyer, Isabella R McDonald, Biagio Cangiano, et al.
The Lancet. Diabetes & Endocrinology|March 7, 2024
Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 yearsIan R Reid, Anne M Horne, Borislav Mihov, et al.
The Lancet. Diabetes & Endocrinology|March 7, 2024
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension studyMaud Robert, Tigran Poghosyan, Delphine Maucort-Boulch, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2024
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trialYiming Mu, Xiaolei Bao, Freddy G Eliaschewitz, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2024
Endocrine health in survivors of adult-onset cancerCornelia S Link-Rachner, Andy Göbel, Nikolai P Jaschke, et al.
The Lancet. Diabetes & Endocrinology|May 26, 2024
Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scoresMugdha V Joglekar, Simranjeet Kaur, Flemming Pociot, et al.
The Lancet. Diabetes & Endocrinology|May 2, 2024
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trialKatrien Benhalima, Kaat Beunen, Nancy Van Wilder, et al.
The Lancet. Diabetes & Endocrinology|May 9, 2024
Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic reviewMoath S Alsaqaaby, Sarah Cooney, Carel W le Roux, et al.
Pageof 93